InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+5.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Burroughs Amy L., Director. Officer active across 2 companies, notably DiaMedica Therapeutics Inc.. In total, 9 filings have been logged. Split: 4 buys · 0 sell. Total volume traded: €305k. History available since 16 August 2021. The latest transaction was disclosed on 16 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
14,583 shares@ US$4.6424.3% of flowCommon StockSEC:0001872564-26-000008:0
150,000 shares0Common StockSEC:0001872564-26-000004:0
21,551 shares@ US$4.64Common StockSEC:0001872564-26-000002:0
23,314 shares@ US$3.870241.8% of flowCommon StockSEC:0001562180-25-005077:0
Ideal exit: 22 Mar 2026 (T+270)
510 shares@ US$5.112.3% of flowCommon StockSEC:0001562180-25-000851:0
Ideal exit: 27 Aug 2025 (T+270)
15,450 shares@ US$7.1597.7% of flowCommon StockSEC:0001562180-24-008254:0
Ideal exit: 1 Sept 2025 (T+270)
17,156 shares@ US$1.537.3% of flowVoting Common Shares, no par value per shareSEC:0001235802-23-000003:0
11,182 shares@ US$3.580.0085% mcap11.3% of flowVoting Common Shares, no par value per shareSEC:0001235802-22-000004:0
44,950 shares@ US$3.150.029% mcap38.7% of flowVoting Common Shares, no par value per shareSEC:0001235802-21-000101:0
Ideal exit: 13 May 2022 (T+270)
9 of 9 declarations
About Burroughs Amy L.
Amy L. Burroughs is a Director at DiaMedica Therapeutics Inc. In this role, she participates in the governance of the company and in strategic decision-making. Her experience is valuable for guiding DiaMedica's initiatives.
